OnKure Therapeutics (OKUR) Return on Equity [ROE] (2021 - 2026)
OnKure Therapeutics (OKUR) reported Return on Equity [ROE] of -34.87% for Q2 2026, up 40.73 percentage points from -75.60% a year earlier and up 16.33 percentage points from the prior quarter.
Powered by 
Analysis
OnKure Therapeutics (OKUR) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, OnKure Therapeutics posted Return on Equity [ROE] of -78.69%, up 5428.46 percentage points from FY2024.
- Return on Equity [ROE] has a four-year change of -2.92 percentage points (FY2021 to FY2025).
- By year, Return on Equity [ROE] came in at -5507.15% in FY2024, -116.06% in FY2022 (-40.29 pp) and -75.77% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q1 2022.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 40.73 percentage points); the low point was Q4 2023 (a drop of 376.95 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -51.20% (Q1 2026), -102.69% (Q4 2025) and -93.48% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | OnKure Therapeutics | 136.90 Mn | -454.00 Mn | - | -38.18% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -38.18% |
| Jun 30, 2026 | -33.55% |
| Mar 31, 2026 | -49.75% |
| Dec 31, 2025 | -99.86% |
| Sep 30, 2025 | -91.08% |
| Jun 30, 2025 | -64.95% |
| Mar 31, 2025 | -46.07% |
| Dec 31, 2023 | -1,180.54% |
| Sep 30, 2023 | -54.49% |
| Jun 30, 2023 | -55.96% |
| Mar 31, 2023 | -331.10% |
| Dec 31, 2022 | -180.58% |
| Sep 30, 2022 | -41.49% |
| Jun 30, 2022 | -37.40% |
| Mar 31, 2022 | -32.23% |
| Dec 31, 2021 | -26.19% |
| Sep 30, 2021 | -21.87% |
| Jun 30, 2021 | -46.75% |
API Access
OnKure Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OKUR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OKUR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OKUR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();